An EORTC phase I study of capecitabine (Xeloda(R)) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer

By Bonnefoi H.   Biganzoli L.   Mauriac L.   Cufer T.   Schaefer P.   Atalay G.   Piccart M.  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1277-1283

Elsevier

Access to resources Recommend Favorite

Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A phase II study

By Kümmel Sherko   Thomas Anke   Paepke Stefan   Schwarz Marion   Heinrich Georg   Wetzel Andrea   Elling Dirk   Kohls Andreas   Lichtenegger Werner   Blohmer Jens-Uwe  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 248-254

Informa Healthcare

Access to resources Recommend Favorite

Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer

By Dixon J.M.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor

By Kwasny W.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 3, 2000-10 ,pp. : 235-241

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

By Esteban E.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 127-133

Springer Publishing Company

Access to resources Recommend Favorite